| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.04 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.36 | 0.05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |